We have developed a platform technology for passive physiologic monitoring with broad applications in chronic disease management. The system will initially be brought to market as a digital health solution for children with asthma. It delivers objective indicators of asthma control paired with clinical insight, to achieve the best outcomes. Initial clinical study conducted at Stanford.